Through this 0.65 CE contact hour course, learn about the definition of precision medicine and its role in CVD prevention and management, the connection between precision medicine and genetics, and the current state of research on CRISPR gene technology. This course will also review a case study on identification and genetic testing for Hypertrophic Cardiomyopathy and Cardiac Amyloidosis.
Learning Objectives
- Define precision medicine and its role in CVD prevention and management.
- Explain the connection between precision medicine and genetics.
- Describe the current state of research on CRISPR gene technology.
- Review a case study on identification and genetic testing for Hypertrophic Cardiomyopathy and Cardiac Amyloidosis.
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
